ResearcherSwansea UniversityNo recent work listed

Gareth Jenkins

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5437-8389; OpenAlex author ID A5015398688. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study. Last author DOI 10.1093/mutage/gead006 ↗
The Impact of a Centralised Pancreatic Cancer Service: a Case Study of Wales, UK. Co-author DOI 10.1007/s11605-020-04612-8 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bilal A. Al-Sarireh · 2 shared papers, 2022–2023 · strength 0.40
- Paper Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study. DOI 10.1093/mutage/gead006 ↗
- Paper The Impact of a Centralised Pancreatic Cancer Service: a Case Study of Wales, UK. DOI 10.1007/s11605-020-04612-8 ↗
Lucy Nichols · 1 shared paper, 2023 · strength 0.22
- Paper Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study. DOI 10.1093/mutage/gead006 ↗
Nicholas George Mowbray · 1 shared paper, 2022 · strength 0.19
- Paper The Impact of a Centralised Pancreatic Cancer Service: a Case Study of Wales, UK. DOI 10.1007/s11605-020-04612-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.